Related Experiment Videos
TrkB receptor ligands promote activity-dependent inhibitory synaptogenesis
1Neurology Research, Veterans Affairs Medical Center and Departments of Neurology and Cell and Developmental Biology, Oregon Health Sciences University, Portland, Oregon 97201, USA. seilf@ohsu.edu
Summary
Brain-derived neurotrophic factor (BDNF) and neurotrophin-4 (NT-4) promote inhibitory synapse development in Purkinje cells. These neurotrophins can substitute for neuronal activity, offering potential therapeutic benefits.
Area of Science:
- Neuroscience
- Developmental Biology
- Cell Biology
Background:
- Neuronal activity is crucial for proper synapse development.
- Neurotrophins are key signaling molecules regulating neuronal survival and function.
- Purkinje cells in the cerebellum form critical inhibitory synapses.
Purpose of the Study:
- To investigate the role of neurotrophins, specifically BDNF and NT-4, in the development of inhibitory synapses on Purkinje cells.
- To determine if neurotrophins can compensate for the absence of neuronal activity in synapse formation.
- To explore the therapeutic potential of neurotrophins in conditions affecting synaptic development.
Main Methods:
- Organotypic cerebellar cultures from newborn mice were used.
- Cultures were exposed to activity-blocking agents and various neurotrophins (BDNF, NT-4, NT-3) or antibodies.
- Synapse development was assessed ultrastructurally, and neuronal activity was measured after recovery.
Main Results:
- TrkB receptor ligands (BDNF, NT-4) restored inhibitory synapse development and normalized activity in cultures blocked from neuronal activity.
- TrkC ligand NT-3 did not rescue synapse development, and activity-blocked cultures showed reduced synapses and hyperactivity.
- Endogenous BDNF and NT-4 are necessary for normal inhibitory synapse formation.
- Antibodies to BDNF and NT-4 prevented activity-dependent hyperinnervation.
Conclusions:
- TrkB receptor ligands, BDNF and NT-4, are potent promoters of inhibitory synaptogenesis.
- Neurotrophins can substitute for neuronal activity in driving the development of inhibitory synapses.
- These findings suggest a therapeutic strategy for neurological disorders characterized by impaired synaptic development.